INVO Fertility (IVF) Accounts Payables (2010 - 2025)

INVO Fertility has disclosed Accounts Payables across 16 years of filings, most recently posting $2.4 million for Q3 2025.

• Quarterly Accounts Payables fell 9.94% year-over-year to $2.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.4 million (down 9.94% YoY) and the FY2024 annual result came in at $3.1 million, up 33.61% from the prior year.
• Accounts Payables climbed to $2.4 million in Q3 2025, from $2.2 million in the prior quarter.
• Across five years, Accounts Payables topped out at $4.8 million in Q1 2025 and bottomed at $306252.0 in Q2 2021.
• The 5-year median for Accounts Payables is $1.8 million (2023), against an average of $1.7 million.
• Year-over-year, Accounts Payables surged 299.65% in 2023 and slipped 9.94% in 2025.
• INVO Fertility's Accounts Payables stood at $443422.0 in 2021, then jumped by 204.23% to $1.3 million in 2022, then surged by 72.74% to $2.3 million in 2023, then soared by 33.61% to $3.1 million in 2024, then decreased by 23.2% to $2.4 million in 2025.
• According to Business Quant data, Accounts Payables over the past three periods registered $2.4 million, $2.2 million, and $4.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.